Health-related quality of life (EQ-5D) among type 2 diabetes mellitus patients treated with dapagliflozin over 2 years
Author:
Affiliation:
1. AstraZeneca LP; Wilmington DE USA
2. AstraZeneca; Molndal Sweden
Publisher
Hindawi Limited
Subject
General Medicine
Reference33 articles.
1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study Group;Lancet,1998
2. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34);UK Prospective Diabetes Study Group;Lancet,1998
3. Standards of medical care in diabetes - 2008;American Diabetes Association;Diabetes Care,2008
4. Glycaemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report;Koro;Diabetes Care,2004
5. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial;Strojek;Diabetes Obes Metab,2011
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression;Health and Quality of Life Outcomes;2024-09-07
2. Patientenberichtete Ergebnisse (PRO) und Erfahrungen (PRE) in der Diabetesversorgung;Die Diabetologie;2024-05-29
3. Person‐reported outcomes in diabetes care: What are they and why are they so important?;Diabetes, Obesity and Metabolism;2024-02-04
4. Association of SGLT‐2 Inhibitors With Treatment Satisfaction and Diabetes‐Specific and General Health Status in Adults With Cardiovascular Disease and Type 2 Diabetes;Journal of the American Heart Association;2023-09-05
5. Effects of Metabolic Medicine and Metabolic Surgery on Patient-Reported Outcomes Among Patients with Type 2 Diabetes;Metabolic Syndrome and Related Disorders;2022-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3